Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catastrophization | 52 | 2024 | 352 | 9.540 |
Why?
|
Pain Threshold | 71 | 2024 | 607 | 8.910 |
Why?
|
Pain | 113 | 2024 | 5101 | 6.900 |
Why?
|
Pain Measurement | 145 | 2024 | 3584 | 6.770 |
Why?
|
Low Back Pain | 39 | 2024 | 989 | 6.630 |
Why?
|
Fibromyalgia | 25 | 2024 | 407 | 5.110 |
Why?
|
Osteoarthritis, Knee | 30 | 2024 | 1251 | 4.220 |
Why?
|
Analgesics, Opioid | 51 | 2024 | 3837 | 2.980 |
Why?
|
Pain, Postoperative | 31 | 2024 | 1768 | 2.640 |
Why?
|
Opioid-Related Disorders | 29 | 2024 | 2188 | 2.530 |
Why?
|
Arthroplasty, Replacement, Knee | 16 | 2024 | 1389 | 2.410 |
Why?
|
Adaptation, Psychological | 23 | 2023 | 2662 | 1.820 |
Why?
|
Pain Perception | 12 | 2023 | 198 | 1.720 |
Why?
|
Hyperalgesia | 13 | 2019 | 527 | 1.660 |
Why?
|
Meditation | 4 | 2024 | 256 | 1.160 |
Why?
|
Arthralgia | 6 | 2022 | 459 | 1.130 |
Why?
|
Diclofenac | 2 | 2017 | 69 | 1.060 |
Why?
|
Sex Characteristics | 11 | 2023 | 2647 | 1.050 |
Why?
|
Biofeedback, Psychology | 2 | 2024 | 117 | 1.030 |
Why?
|
Humans | 342 | 2024 | 767040 | 0.980 |
Why?
|
Analgesia | 6 | 2024 | 461 | 0.980 |
Why?
|
Analgesics | 10 | 2024 | 1071 | 0.950 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 4 | 2022 | 169 | 0.930 |
Why?
|
Adult | 175 | 2024 | 223317 | 0.850 |
Why?
|
Physical Stimulation | 15 | 2021 | 514 | 0.820 |
Why?
|
Anxiety | 16 | 2024 | 4670 | 0.800 |
Why?
|
Back Pain | 6 | 2023 | 547 | 0.790 |
Why?
|
Disability Evaluation | 13 | 2016 | 1829 | 0.760 |
Why?
|
Female | 208 | 2024 | 396660 | 0.750 |
Why?
|
Middle Aged | 148 | 2024 | 223233 | 0.740 |
Why?
|
Hydrocortisone | 7 | 2021 | 1840 | 0.720 |
Why?
|
Toothache | 7 | 2011 | 31 | 0.720 |
Why?
|
Male | 191 | 2024 | 364203 | 0.710 |
Why?
|
Football | 2 | 2023 | 504 | 0.700 |
Why?
|
Mastectomy | 11 | 2024 | 1861 | 0.680 |
Why?
|
Brain | 37 | 2024 | 27163 | 0.660 |
Why?
|
Depression | 25 | 2024 | 8234 | 0.650 |
Why?
|
Music | 4 | 2024 | 248 | 0.650 |
Why?
|
Neuralgia | 8 | 2022 | 619 | 0.640 |
Why?
|
Arthritis | 3 | 2010 | 684 | 0.640 |
Why?
|
Psychophysics | 11 | 2016 | 292 | 0.640 |
Why?
|
Hot Temperature | 17 | 2017 | 1441 | 0.590 |
Why?
|
Mind-Body Therapies | 1 | 2021 | 294 | 0.570 |
Why?
|
Stress, Psychological | 12 | 2024 | 4526 | 0.560 |
Why?
|
Individuality | 4 | 2012 | 303 | 0.560 |
Why?
|
Fear | 7 | 2023 | 1496 | 0.550 |
Why?
|
Migraine Disorders | 4 | 2024 | 1712 | 0.550 |
Why?
|
Atropine | 1 | 2017 | 243 | 0.550 |
Why?
|
Treatment Outcome | 34 | 2024 | 65295 | 0.550 |
Why?
|
Xerostomia | 1 | 2017 | 94 | 0.550 |
Why?
|
Diabetic Neuropathies | 1 | 2020 | 409 | 0.540 |
Why?
|
Affect | 11 | 2024 | 1494 | 0.540 |
Why?
|
Cerebral Cortex | 11 | 2023 | 5754 | 0.540 |
Why?
|
Capsaicin | 6 | 2013 | 233 | 0.540 |
Why?
|
Brain Mapping | 15 | 2023 | 6597 | 0.540 |
Why?
|
Temporomandibular Joint Dysfunction Syndrome | 3 | 2012 | 24 | 0.540 |
Why?
|
Cold Temperature | 12 | 2017 | 793 | 0.540 |
Why?
|
Androgens | 4 | 2017 | 1281 | 0.520 |
Why?
|
Neural Pathways | 8 | 2020 | 3078 | 0.520 |
Why?
|
Behavior Therapy | 3 | 2022 | 886 | 0.520 |
Why?
|
Testosterone | 7 | 2018 | 2490 | 0.520 |
Why?
|
Sleep Initiation and Maintenance Disorders | 6 | 2024 | 1107 | 0.510 |
Why?
|
Rheumatic Diseases | 3 | 2023 | 659 | 0.510 |
Why?
|
Breast Neoplasms | 13 | 2024 | 21178 | 0.500 |
Why?
|
Neural Inhibition | 4 | 2008 | 589 | 0.490 |
Why?
|
Cross-Sectional Studies | 30 | 2023 | 26325 | 0.490 |
Why?
|
Temporomandibular Joint Disorders | 3 | 2021 | 226 | 0.470 |
Why?
|
Psychology | 4 | 2020 | 353 | 0.470 |
Why?
|
Somatosensory Cortex | 4 | 2020 | 506 | 0.470 |
Why?
|
Limbic System | 1 | 2017 | 418 | 0.470 |
Why?
|
Helplessness, Learned | 3 | 2012 | 25 | 0.460 |
Why?
|
Prefrontal Cortex | 6 | 2020 | 2224 | 0.460 |
Why?
|
Interleukin-6 | 6 | 2024 | 3227 | 0.450 |
Why?
|
Disabled Persons | 4 | 2024 | 1209 | 0.440 |
Why?
|
Thinking | 2 | 2024 | 320 | 0.440 |
Why?
|
Acupuncture Therapy | 4 | 2020 | 485 | 0.430 |
Why?
|
Quality of Life | 12 | 2024 | 13485 | 0.430 |
Why?
|
Neuralgia, Postherpetic | 2 | 2019 | 41 | 0.430 |
Why?
|
Clinical Trials as Topic | 7 | 2024 | 8048 | 0.430 |
Why?
|
Self Report | 14 | 2024 | 3773 | 0.430 |
Why?
|
Aged | 80 | 2024 | 171319 | 0.420 |
Why?
|
Placebo Effect | 1 | 2017 | 516 | 0.420 |
Why?
|
Music Therapy | 3 | 2020 | 111 | 0.420 |
Why?
|
Attention | 4 | 2019 | 2413 | 0.420 |
Why?
|
Habituation, Psychophysiologic | 3 | 2016 | 144 | 0.410 |
Why?
|
Self Efficacy | 1 | 2016 | 643 | 0.390 |
Why?
|
Patient Preference | 2 | 2019 | 947 | 0.390 |
Why?
|
Mastectomy, Segmental | 2 | 2018 | 974 | 0.380 |
Why?
|
Arthritis, Rheumatoid | 7 | 2019 | 3778 | 0.370 |
Why?
|
Pilot Projects | 14 | 2024 | 8732 | 0.360 |
Why?
|
Pressure | 9 | 2020 | 1172 | 0.360 |
Why?
|
Exercise | 3 | 2020 | 5954 | 0.350 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2017 | 2270 | 0.350 |
Why?
|
Attitude to Health | 6 | 2017 | 2023 | 0.350 |
Why?
|
Benzothiazoles | 1 | 2011 | 244 | 0.340 |
Why?
|
Chronic Disease | 20 | 2023 | 9362 | 0.340 |
Why?
|
Hydromorphone | 2 | 2021 | 70 | 0.340 |
Why?
|
Breast | 1 | 2018 | 1972 | 0.330 |
Why?
|
Prospective Studies | 25 | 2024 | 54886 | 0.330 |
Why?
|
Temporal Lobe | 1 | 2017 | 1717 | 0.320 |
Why?
|
Perception | 4 | 2022 | 1205 | 0.320 |
Why?
|
Hallucinogens | 2 | 2023 | 212 | 0.320 |
Why?
|
Sensation | 2 | 2013 | 331 | 0.310 |
Why?
|
Saliva | 6 | 2021 | 853 | 0.310 |
Why?
|
Psychophysiology | 1 | 2009 | 136 | 0.310 |
Why?
|
Dopamine Agonists | 1 | 2011 | 346 | 0.310 |
Why?
|
Receptors, GABA | 8 | 2023 | 312 | 0.310 |
Why?
|
Longitudinal Studies | 17 | 2023 | 14766 | 0.310 |
Why?
|
Sleep | 9 | 2023 | 4816 | 0.300 |
Why?
|
Affective Symptoms | 2 | 2012 | 418 | 0.300 |
Why?
|
Physician-Patient Relations | 3 | 2019 | 3266 | 0.300 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2009 | 113 | 0.300 |
Why?
|
Self-Assessment | 2 | 2010 | 400 | 0.300 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2023 | 69 | 0.300 |
Why?
|
Neuropsychological Tests | 8 | 2016 | 7121 | 0.300 |
Why?
|
Restless Legs Syndrome | 1 | 2011 | 235 | 0.300 |
Why?
|
Regression Analysis | 11 | 2013 | 6331 | 0.290 |
Why?
|
Anemia, Sickle Cell | 4 | 2016 | 1065 | 0.290 |
Why?
|
Educational Status | 5 | 2021 | 2511 | 0.290 |
Why?
|
Osteoarthritis | 2 | 2018 | 1072 | 0.290 |
Why?
|
Young Adult | 46 | 2024 | 59980 | 0.290 |
Why?
|
Ketamine | 2 | 2024 | 527 | 0.290 |
Why?
|
Nerve Net | 6 | 2020 | 2307 | 0.290 |
Why?
|
Pain Clinics | 3 | 2003 | 50 | 0.280 |
Why?
|
Phenotype | 7 | 2024 | 16718 | 0.280 |
Why?
|
Buprenorphine | 4 | 2020 | 667 | 0.280 |
Why?
|
Social Adjustment | 2 | 2006 | 634 | 0.280 |
Why?
|
Magnetic Resonance Imaging | 35 | 2023 | 36582 | 0.280 |
Why?
|
Anticipation, Psychological | 2 | 2018 | 90 | 0.280 |
Why?
|
Sciatica | 2 | 2006 | 97 | 0.280 |
Why?
|
Hyperesthesia | 1 | 2006 | 23 | 0.270 |
Why?
|
Diagnostic Techniques, Neurological | 2 | 2019 | 62 | 0.270 |
Why?
|
Patient Compliance | 2 | 2019 | 2697 | 0.270 |
Why?
|
Maryland | 11 | 2011 | 277 | 0.260 |
Why?
|
Vagus Nerve Stimulation | 3 | 2022 | 228 | 0.260 |
Why?
|
Social Behavior Disorders | 1 | 2006 | 100 | 0.260 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3414 | 0.260 |
Why?
|
Sex Factors | 14 | 2024 | 10622 | 0.260 |
Why?
|
Cognition Disorders | 3 | 2020 | 3968 | 0.260 |
Why?
|
Burns | 2 | 2007 | 1902 | 0.260 |
Why?
|
Double-Blind Method | 14 | 2024 | 12451 | 0.260 |
Why?
|
Thalamus | 3 | 2023 | 1040 | 0.260 |
Why?
|
Activities of Daily Living | 8 | 2021 | 2429 | 0.250 |
Why?
|
Empathy | 4 | 2023 | 474 | 0.250 |
Why?
|
Punishment | 3 | 2020 | 95 | 0.250 |
Why?
|
Sensory Thresholds | 4 | 2020 | 377 | 0.250 |
Why?
|
Reward | 4 | 2020 | 980 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2024 | 10393 | 0.240 |
Why?
|
Androgen Antagonists | 3 | 2018 | 1412 | 0.240 |
Why?
|
Diskectomy | 1 | 2006 | 203 | 0.240 |
Why?
|
Minority Groups | 8 | 2011 | 1214 | 0.240 |
Why?
|
Sleep Stages | 1 | 2009 | 705 | 0.240 |
Why?
|
Narcotic Antagonists | 2 | 2012 | 591 | 0.240 |
Why?
|
Catechol O-Methyltransferase | 3 | 2013 | 251 | 0.230 |
Why?
|
Social Perception | 1 | 2008 | 435 | 0.230 |
Why?
|
Pain, Intractable | 1 | 2005 | 132 | 0.230 |
Why?
|
Self Disclosure | 1 | 2005 | 248 | 0.230 |
Why?
|
Feasibility Studies | 4 | 2024 | 5311 | 0.230 |
Why?
|
Health Services Accessibility | 5 | 2019 | 5519 | 0.230 |
Why?
|
Dental Care | 5 | 2011 | 285 | 0.230 |
Why?
|
Gyrus Cinguli | 3 | 2020 | 1118 | 0.230 |
Why?
|
Prejudice | 1 | 2008 | 569 | 0.220 |
Why?
|
Neurosciences | 1 | 2008 | 384 | 0.220 |
Why?
|
Manipulation, Spinal | 2 | 2020 | 21 | 0.220 |
Why?
|
Hypochondriasis | 1 | 2004 | 93 | 0.220 |
Why?
|
Patient Participation | 2 | 2023 | 1444 | 0.220 |
Why?
|
Video Games | 2 | 2024 | 202 | 0.220 |
Why?
|
Narcotics | 2 | 2004 | 332 | 0.210 |
Why?
|
Rest | 3 | 2017 | 941 | 0.210 |
Why?
|
Neuroglia | 3 | 2019 | 960 | 0.210 |
Why?
|
Risk Factors | 18 | 2024 | 74886 | 0.210 |
Why?
|
Case-Control Studies | 13 | 2022 | 22254 | 0.210 |
Why?
|
Models, Psychological | 4 | 2013 | 823 | 0.200 |
Why?
|
Social Support | 3 | 2022 | 2192 | 0.200 |
Why?
|
Scleroderma, Systemic | 1 | 2006 | 346 | 0.200 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5886 | 0.200 |
Why?
|
Severity of Illness Index | 14 | 2024 | 15925 | 0.190 |
Why?
|
Telemedicine | 4 | 2024 | 3110 | 0.190 |
Why?
|
Tooth Diseases | 3 | 2011 | 73 | 0.190 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2016 | 6023 | 0.190 |
Why?
|
Naloxone | 1 | 2004 | 372 | 0.190 |
Why?
|
Nonverbal Communication | 1 | 2022 | 62 | 0.190 |
Why?
|
Positron-Emission Tomography | 9 | 2024 | 6550 | 0.190 |
Why?
|
Brain Stem | 2 | 2017 | 858 | 0.190 |
Why?
|
Predictive Value of Tests | 10 | 2016 | 15424 | 0.190 |
Why?
|
Physicians' Offices | 3 | 2011 | 60 | 0.190 |
Why?
|
Suicide, Attempted | 3 | 2013 | 1413 | 0.190 |
Why?
|
Adolescent | 26 | 2024 | 89046 | 0.190 |
Why?
|
Physical Fitness | 1 | 2006 | 744 | 0.190 |
Why?
|
Cohort Studies | 14 | 2024 | 41718 | 0.190 |
Why?
|
Pituitary-Adrenal Function Tests | 2 | 2012 | 30 | 0.180 |
Why?
|
Aged, 80 and over | 16 | 2024 | 59548 | 0.180 |
Why?
|
Lateral Thalamic Nuclei | 1 | 2020 | 9 | 0.180 |
Why?
|
Cannabinoids | 1 | 2023 | 174 | 0.180 |
Why?
|
Statistics as Topic | 6 | 2015 | 2350 | 0.180 |
Why?
|
Nociceptors | 1 | 2004 | 460 | 0.180 |
Why?
|
Receptors, Opioid, mu | 3 | 2013 | 167 | 0.180 |
Why?
|
Ventral Thalamic Nuclei | 1 | 2020 | 43 | 0.180 |
Why?
|
Follow-Up Studies | 12 | 2018 | 39317 | 0.180 |
Why?
|
Depressive Disorder | 3 | 2007 | 3721 | 0.180 |
Why?
|
Anxiety Disorders | 3 | 2016 | 2745 | 0.180 |
Why?
|
Genetic Markers | 1 | 2006 | 2602 | 0.170 |
Why?
|
Blood Pressure | 4 | 2012 | 8531 | 0.170 |
Why?
|
Neoplasms | 7 | 2024 | 22350 | 0.170 |
Why?
|
Knee Joint | 3 | 2023 | 1683 | 0.170 |
Why?
|
Mouth Diseases | 3 | 2011 | 239 | 0.170 |
Why?
|
Methadone | 3 | 2021 | 317 | 0.170 |
Why?
|
Agnosia | 1 | 2020 | 67 | 0.170 |
Why?
|
Persian Gulf Syndrome | 1 | 2020 | 48 | 0.170 |
Why?
|
Mood Disorders | 2 | 2014 | 1129 | 0.170 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2012 | 347 | 0.170 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2024 | 878 | 0.160 |
Why?
|
Pituitary-Adrenal System | 2 | 2021 | 555 | 0.160 |
Why?
|
Myocardial Contraction | 1 | 2005 | 1516 | 0.160 |
Why?
|
Quarantine | 1 | 2021 | 186 | 0.160 |
Why?
|
Child Abuse | 2 | 2024 | 1090 | 0.160 |
Why?
|
Comorbidity | 11 | 2021 | 10582 | 0.160 |
Why?
|
Aging | 4 | 2017 | 8729 | 0.160 |
Why?
|
Patient Satisfaction | 7 | 2017 | 3488 | 0.160 |
Why?
|
Analysis of Variance | 8 | 2017 | 6215 | 0.160 |
Why?
|
Touch Perception | 1 | 2020 | 106 | 0.160 |
Why?
|
Sensation Disorders | 1 | 2019 | 160 | 0.160 |
Why?
|
Medication Adherence | 3 | 2017 | 2191 | 0.160 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2021 | 703 | 0.160 |
Why?
|
Aromatase Inhibitors | 1 | 2022 | 519 | 0.150 |
Why?
|
Electromyography | 1 | 2024 | 1398 | 0.150 |
Why?
|
Musculoskeletal Manipulations | 1 | 2018 | 24 | 0.150 |
Why?
|
Anger | 1 | 2021 | 402 | 0.150 |
Why?
|
Morphine | 2 | 2020 | 658 | 0.150 |
Why?
|
Anesthesia, Conduction | 1 | 2021 | 264 | 0.150 |
Why?
|
Poverty | 8 | 2011 | 2719 | 0.150 |
Why?
|
Checklist | 2 | 2015 | 842 | 0.150 |
Why?
|
Abdominal Pain | 1 | 2024 | 1069 | 0.140 |
Why?
|
beta-Endorphin | 1 | 2017 | 43 | 0.140 |
Why?
|
Spin Labels | 1 | 2019 | 334 | 0.140 |
Why?
|
Perioperative Period | 1 | 2019 | 252 | 0.140 |
Why?
|
Self-Injurious Behavior | 1 | 2023 | 571 | 0.140 |
Why?
|
Emergency Service, Hospital | 10 | 2024 | 7871 | 0.140 |
Why?
|
Cross-Over Studies | 7 | 2020 | 2105 | 0.140 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2019 | 638 | 0.140 |
Why?
|
Musculoskeletal Diseases | 1 | 2023 | 599 | 0.140 |
Why?
|
United States | 14 | 2024 | 72971 | 0.140 |
Why?
|
Leuprolide | 1 | 2018 | 313 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 292 | 0.130 |
Why?
|
Suicide | 1 | 2007 | 1606 | 0.130 |
Why?
|
Hand | 2 | 2021 | 910 | 0.130 |
Why?
|
Administration, Cutaneous | 2 | 2017 | 715 | 0.130 |
Why?
|
Oxycodone | 1 | 2017 | 144 | 0.130 |
Why?
|
Preoperative Period | 1 | 2018 | 564 | 0.130 |
Why?
|
Psychiatry | 1 | 2008 | 1715 | 0.130 |
Why?
|
Basal Ganglia | 1 | 2019 | 549 | 0.130 |
Why?
|
Reference Values | 6 | 2015 | 4918 | 0.130 |
Why?
|
Avoidance Learning | 2 | 2016 | 248 | 0.130 |
Why?
|
Health Status | 5 | 2010 | 4091 | 0.130 |
Why?
|
Vibration | 1 | 2018 | 334 | 0.130 |
Why?
|
Substance P | 1 | 2017 | 331 | 0.130 |
Why?
|
Mental Disorders | 5 | 2021 | 6873 | 0.130 |
Why?
|
Medical Informatics Applications | 1 | 2017 | 180 | 0.130 |
Why?
|
Resilience, Psychological | 1 | 2024 | 807 | 0.130 |
Why?
|
Office Visits | 2 | 2011 | 595 | 0.120 |
Why?
|
Primary Dysautonomias | 1 | 2015 | 28 | 0.120 |
Why?
|
Gels | 1 | 2016 | 421 | 0.120 |
Why?
|
Reproducibility of Results | 7 | 2023 | 20169 | 0.120 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2016 | 240 | 0.120 |
Why?
|
Electronics | 1 | 2016 | 316 | 0.120 |
Why?
|
Wakefulness | 3 | 2012 | 1282 | 0.120 |
Why?
|
Hypnosis | 2 | 2012 | 83 | 0.120 |
Why?
|
Vagus Nerve | 1 | 2017 | 458 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2019 | 812 | 0.120 |
Why?
|
Erythropoiesis | 1 | 2018 | 691 | 0.120 |
Why?
|
Estrogen Replacement Therapy | 1 | 2001 | 1209 | 0.120 |
Why?
|
Dental Offices | 2 | 2011 | 13 | 0.120 |
Why?
|
Risk Assessment | 5 | 2022 | 24299 | 0.120 |
Why?
|
Self Concept | 1 | 2020 | 1041 | 0.110 |
Why?
|
Gastric Bypass | 1 | 2023 | 820 | 0.110 |
Why?
|
Administration, Topical | 1 | 2016 | 703 | 0.110 |
Why?
|
Cyclopropanes | 1 | 2015 | 436 | 0.110 |
Why?
|
Pandemics | 3 | 2023 | 8736 | 0.110 |
Why?
|
Estrogens | 1 | 2001 | 1536 | 0.110 |
Why?
|
Sensory System Agents | 2 | 2013 | 24 | 0.110 |
Why?
|
Opiate Substitution Treatment | 2 | 2016 | 452 | 0.110 |
Why?
|
Erythropoietin | 1 | 2018 | 718 | 0.110 |
Why?
|
Polysomnography | 6 | 2015 | 1868 | 0.110 |
Why?
|
Linear Models | 4 | 2021 | 5875 | 0.110 |
Why?
|
Age Factors | 7 | 2024 | 18401 | 0.110 |
Why?
|
Autonomic Nervous System | 1 | 2019 | 707 | 0.110 |
Why?
|
Corpus Striatum | 1 | 2020 | 1217 | 0.110 |
Why?
|
Psychological Tests | 4 | 2010 | 642 | 0.110 |
Why?
|
Facial Pain | 2 | 2011 | 119 | 0.110 |
Why?
|
Risk | 2 | 2017 | 9606 | 0.110 |
Why?
|
Motor Cortex | 1 | 2020 | 1005 | 0.110 |
Why?
|
Preoperative Care | 1 | 2022 | 2252 | 0.100 |
Why?
|
Frontal Lobe | 2 | 2020 | 1408 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2018 | 1536 | 0.100 |
Why?
|
Self Care | 2 | 2009 | 800 | 0.100 |
Why?
|
Medicine | 1 | 2020 | 944 | 0.100 |
Why?
|
Consensus | 3 | 2023 | 3207 | 0.100 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2012 | 56 | 0.100 |
Why?
|
Interpersonal Relations | 3 | 2010 | 1432 | 0.100 |
Why?
|
Cytokines | 2 | 2018 | 7446 | 0.100 |
Why?
|
Motivation | 2 | 2022 | 2021 | 0.100 |
Why?
|
Sleep Deprivation | 3 | 2008 | 848 | 0.100 |
Why?
|
Lymph Node Excision | 1 | 2018 | 1267 | 0.100 |
Why?
|
Hip Fractures | 1 | 2020 | 997 | 0.100 |
Why?
|
Postmenopause | 1 | 2001 | 2518 | 0.100 |
Why?
|
Administration, Oral | 3 | 2016 | 4026 | 0.100 |
Why?
|
Pulpitis | 2 | 2004 | 28 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2023 | 1293 | 0.100 |
Why?
|
Psychomotor Performance | 1 | 2020 | 1886 | 0.100 |
Why?
|
Single-Blind Method | 3 | 2020 | 1587 | 0.100 |
Why?
|
Biosensing Techniques | 1 | 2017 | 641 | 0.100 |
Why?
|
Interview, Psychological | 2 | 2012 | 810 | 0.090 |
Why?
|
Hormone Replacement Therapy | 1 | 2017 | 756 | 0.090 |
Why?
|
Somatoform Disorders | 2 | 2013 | 425 | 0.090 |
Why?
|
Neuronal Plasticity | 1 | 2020 | 1446 | 0.090 |
Why?
|
Prostatic Neoplasms | 3 | 2018 | 11097 | 0.090 |
Why?
|
Antirheumatic Agents | 2 | 2019 | 1379 | 0.090 |
Why?
|
Circadian Rhythm | 2 | 2021 | 2591 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2018 | 872 | 0.090 |
Why?
|
Tooth Injuries | 1 | 2011 | 17 | 0.090 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 370 | 0.090 |
Why?
|
Health Surveys | 3 | 2016 | 4056 | 0.090 |
Why?
|
ROC Curve | 2 | 2015 | 3618 | 0.090 |
Why?
|
Guidelines as Topic | 2 | 2015 | 1396 | 0.090 |
Why?
|
Cognition | 3 | 2018 | 7059 | 0.090 |
Why?
|
Dentists | 2 | 2011 | 176 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3828 | 0.090 |
Why?
|
Psychotropic Drugs | 2 | 2014 | 881 | 0.090 |
Why?
|
Acute Disease | 3 | 2008 | 7236 | 0.090 |
Why?
|
Visual Perception | 1 | 2019 | 1392 | 0.090 |
Why?
|
Choline | 2 | 2023 | 511 | 0.090 |
Why?
|
Logistic Models | 4 | 2015 | 13284 | 0.090 |
Why?
|
Choice Behavior | 1 | 2016 | 848 | 0.090 |
Why?
|
Placebos | 2 | 2019 | 1660 | 0.090 |
Why?
|
Creatine | 2 | 2023 | 424 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2015 | 4855 | 0.090 |
Why?
|
Alabama | 2 | 2001 | 112 | 0.090 |
Why?
|
Dentist-Patient Relations | 1 | 2010 | 30 | 0.090 |
Why?
|
Vasopressins | 1 | 2011 | 358 | 0.090 |
Why?
|
Computers, Handheld | 1 | 2012 | 211 | 0.090 |
Why?
|
Substance-Related Disorders | 3 | 2017 | 4422 | 0.080 |
Why?
|
Aspartic Acid | 2 | 2023 | 575 | 0.080 |
Why?
|
Observer Variation | 2 | 2006 | 2616 | 0.080 |
Why?
|
Immersion | 1 | 2009 | 37 | 0.080 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 2698 | 0.080 |
Why?
|
Pelvic Pain | 1 | 2012 | 300 | 0.080 |
Why?
|
Naltrexone | 1 | 2012 | 319 | 0.080 |
Why?
|
Thermosensing | 1 | 2009 | 56 | 0.080 |
Why?
|
Hyperemia | 1 | 2010 | 223 | 0.080 |
Why?
|
Models, Statistical | 1 | 2024 | 5098 | 0.080 |
Why?
|
Conditioning, Classical | 1 | 2012 | 368 | 0.080 |
Why?
|
Prognosis | 5 | 2018 | 29963 | 0.080 |
Why?
|
Collateral Circulation | 1 | 1990 | 289 | 0.080 |
Why?
|
Oxygen | 3 | 2016 | 4252 | 0.080 |
Why?
|
Journalism | 1 | 2008 | 7 | 0.080 |
Why?
|
Cost-Benefit Analysis | 4 | 2023 | 5537 | 0.080 |
Why?
|
GTP Cyclohydrolase | 1 | 2008 | 46 | 0.080 |
Why?
|
Multivariate Analysis | 5 | 2021 | 12069 | 0.080 |
Why?
|
Polymorphism, Genetic | 3 | 2008 | 4247 | 0.080 |
Why?
|
Social Isolation | 2 | 2022 | 366 | 0.080 |
Why?
|
Telephone | 2 | 2011 | 629 | 0.080 |
Why?
|
Patient Selection | 3 | 2024 | 4256 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4349 | 0.080 |
Why?
|
Gastroesophageal Reflux | 1 | 2016 | 834 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2010 | 3851 | 0.070 |
Why?
|
Communication Barriers | 1 | 2011 | 419 | 0.070 |
Why?
|
Confidence Intervals | 2 | 2015 | 2920 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2023 | 3684 | 0.070 |
Why?
|
Executive Function | 1 | 2016 | 1396 | 0.070 |
Why?
|
Factor Analysis, Statistical | 3 | 2013 | 1002 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2016 | 8940 | 0.070 |
Why?
|
Cerebellum | 1 | 2015 | 1521 | 0.070 |
Why?
|
Pharmaceutical Services | 1 | 2009 | 145 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1743 | 0.070 |
Why?
|
Public-Private Sector Partnerships | 2 | 2021 | 123 | 0.070 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1889 | 0.070 |
Why?
|
Motor Activity | 2 | 2013 | 2713 | 0.070 |
Why?
|
Terminology as Topic | 2 | 2013 | 1540 | 0.070 |
Why?
|
Personality Inventory | 1 | 2009 | 1018 | 0.070 |
Why?
|
Time Factors | 5 | 2017 | 40154 | 0.070 |
Why?
|
Pharmacists | 1 | 2009 | 261 | 0.070 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2011 | 627 | 0.070 |
Why?
|
Neurologic Examination | 1 | 2009 | 913 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2015 | 16036 | 0.070 |
Why?
|
Professional-Patient Relations | 1 | 2011 | 724 | 0.070 |
Why?
|
Veterans | 1 | 2020 | 2666 | 0.060 |
Why?
|
Upper Extremity | 2 | 2021 | 684 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2012 | 963 | 0.060 |
Why?
|
Health Literacy | 1 | 2011 | 466 | 0.060 |
Why?
|
Cost of Illness | 4 | 2022 | 1951 | 0.060 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3431 | 0.060 |
Why?
|
Arm | 1 | 2008 | 591 | 0.060 |
Why?
|
Neurotic Disorders | 1 | 2005 | 76 | 0.060 |
Why?
|
Fractures, Bone | 1 | 2017 | 2062 | 0.060 |
Why?
|
Body Mass Index | 1 | 2023 | 13048 | 0.060 |
Why?
|
Headache Disorders | 1 | 2007 | 152 | 0.060 |
Why?
|
Cardiography, Impedance | 1 | 2005 | 40 | 0.060 |
Why?
|
Angiography | 1 | 1990 | 1597 | 0.060 |
Why?
|
Hepatitis C | 1 | 2015 | 1594 | 0.060 |
Why?
|
Quality-Adjusted Life Years | 2 | 2022 | 1741 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2010 | 1027 | 0.060 |
Why?
|
Treatment Failure | 1 | 2011 | 2658 | 0.060 |
Why?
|
Neck Pain | 2 | 2023 | 191 | 0.060 |
Why?
|
Sex Distribution | 2 | 2009 | 2276 | 0.060 |
Why?
|
Prevalence | 4 | 2021 | 15851 | 0.060 |
Why?
|
Coronary Circulation | 1 | 1990 | 1603 | 0.060 |
Why?
|
Models, Neurological | 1 | 2012 | 1747 | 0.060 |
Why?
|
Personality | 2 | 2022 | 559 | 0.060 |
Why?
|
Injury Severity Score | 1 | 2007 | 1049 | 0.060 |
Why?
|
Emotions | 2 | 2020 | 2760 | 0.060 |
Why?
|
Shoulder Pain | 1 | 2024 | 152 | 0.050 |
Why?
|
Research Design | 3 | 2024 | 6210 | 0.050 |
Why?
|
Reaction Time | 1 | 2010 | 2086 | 0.050 |
Why?
|
Disease Progression | 2 | 2018 | 13646 | 0.050 |
Why?
|
Skin | 1 | 2017 | 4499 | 0.050 |
Why?
|
Electric Stimulation Therapy | 1 | 2009 | 635 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4813 | 0.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2011 | 1902 | 0.050 |
Why?
|
Skin Temperature | 1 | 2003 | 96 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1660 | 0.050 |
Why?
|
Sleep, REM | 1 | 2005 | 593 | 0.050 |
Why?
|
Water | 2 | 2011 | 1419 | 0.050 |
Why?
|
Minocycline | 1 | 2023 | 170 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 4 | 2011 | 18063 | 0.050 |
Why?
|
Plant Preparations | 1 | 2022 | 94 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2013 | 8535 | 0.050 |
Why?
|
Astrocytes | 2 | 2020 | 1352 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 3 | 2011 | 3232 | 0.050 |
Why?
|
Lumbar Vertebrae | 2 | 2009 | 1885 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2008 | 2428 | 0.040 |
Why?
|
Spouses | 1 | 2003 | 286 | 0.040 |
Why?
|
Pyridostigmine Bromide | 1 | 2020 | 32 | 0.040 |
Why?
|
Gulf War | 1 | 2020 | 33 | 0.040 |
Why?
|
Loneliness | 1 | 2022 | 211 | 0.040 |
Why?
|
Drug Resistance | 1 | 2006 | 1592 | 0.040 |
Why?
|
Tourniquets | 1 | 2001 | 111 | 0.040 |
Why?
|
Inflammation | 3 | 2023 | 10869 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2006 | 1312 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2024 | 712 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2022 | 15824 | 0.040 |
Why?
|
Drug Tolerance | 1 | 2021 | 365 | 0.040 |
Why?
|
Patient-Centered Care | 1 | 2010 | 1444 | 0.040 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3700 | 0.040 |
Why?
|
Health Behavior | 2 | 2009 | 2650 | 0.040 |
Why?
|
Genotype | 4 | 2019 | 13035 | 0.040 |
Why?
|
Injections, Intra-Articular | 1 | 2020 | 284 | 0.040 |
Why?
|
Arousal | 1 | 2005 | 1174 | 0.040 |
Why?
|
Functional Laterality | 1 | 2006 | 2245 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4746 | 0.040 |
Why?
|
HIV Infections | 3 | 2022 | 17542 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2563 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2022 | 996 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1733 | 0.040 |
Why?
|
Coronary Angiography | 1 | 1990 | 4525 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2018 | 157 | 0.040 |
Why?
|
Attitude | 1 | 2023 | 769 | 0.040 |
Why?
|
New York City | 1 | 2020 | 736 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2023 | 713 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2009 | 2075 | 0.040 |
Why?
|
Central Nervous System | 1 | 2005 | 1345 | 0.040 |
Why?
|
Facial Expression | 1 | 2022 | 515 | 0.040 |
Why?
|
Gastrectomy | 1 | 2023 | 693 | 0.040 |
Why?
|
Computer Simulation | 2 | 2022 | 6260 | 0.040 |
Why?
|
Temperature | 2 | 2016 | 2232 | 0.040 |
Why?
|
Capsules | 1 | 2017 | 193 | 0.040 |
Why?
|
Carbon Radioisotopes | 1 | 2018 | 544 | 0.040 |
Why?
|
Income | 3 | 2011 | 1877 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 2 | 2020 | 2421 | 0.030 |
Why?
|
Neurons, Afferent | 1 | 2019 | 498 | 0.030 |
Why?
|
Acetamides | 1 | 2018 | 259 | 0.030 |
Why?
|
Qualitative Research | 2 | 2024 | 3139 | 0.030 |
Why?
|
Public Policy | 1 | 2021 | 551 | 0.030 |
Why?
|
Anisotropy | 1 | 2020 | 1289 | 0.030 |
Why?
|
South Africa | 1 | 2022 | 1873 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1137 | 0.030 |
Why?
|
Syndrome | 1 | 2022 | 3271 | 0.030 |
Why?
|
Neuroimmunomodulation | 1 | 2018 | 186 | 0.030 |
Why?
|
Incidence | 3 | 2015 | 21526 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1002 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 1999 | 638 | 0.030 |
Why?
|
Ferritins | 1 | 2018 | 601 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2015 | 10748 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2021 | 1182 | 0.030 |
Why?
|
Kuwait | 1 | 2015 | 94 | 0.030 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2015 | 300 | 0.030 |
Why?
|
Psychometrics | 1 | 2004 | 3060 | 0.030 |
Why?
|
Prescription Drugs | 2 | 2013 | 635 | 0.030 |
Why?
|
Trigeminal Nerve | 1 | 2016 | 248 | 0.030 |
Why?
|
Metabolism | 1 | 2016 | 193 | 0.030 |
Why?
|
Patient Discharge | 1 | 2007 | 3467 | 0.030 |
Why?
|
Socioeconomic Factors | 3 | 2013 | 7848 | 0.030 |
Why?
|
United States Department of Agriculture | 1 | 2014 | 47 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1345 | 0.030 |
Why?
|
Patients | 1 | 2020 | 908 | 0.030 |
Why?
|
Lipoproteins | 1 | 2018 | 871 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 14672 | 0.030 |
Why?
|
Drug-Seeking Behavior | 1 | 2013 | 45 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2001 | 839 | 0.030 |
Why?
|
Interviews as Topic | 2 | 2011 | 2741 | 0.030 |
Why?
|
Insulin | 2 | 2018 | 6602 | 0.030 |
Why?
|
Blood Glucose | 2 | 2018 | 6421 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1672 | 0.030 |
Why?
|
Hydrocodone | 1 | 2012 | 48 | 0.030 |
Why?
|
Opioid Peptides | 1 | 2012 | 37 | 0.030 |
Why?
|
Ischemia | 1 | 2001 | 1905 | 0.020 |
Why?
|
Social Class | 2 | 2011 | 2007 | 0.020 |
Why?
|
Phytotherapy | 1 | 2014 | 298 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 771 | 0.020 |
Why?
|
Maxillofacial Injuries | 1 | 2011 | 32 | 0.020 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2011 | 87 | 0.020 |
Why?
|
Neurofeedback | 1 | 2012 | 50 | 0.020 |
Why?
|
Focus Groups | 2 | 2009 | 1460 | 0.020 |
Why?
|
Receptors, Vasopressin | 1 | 2011 | 106 | 0.020 |
Why?
|
Exhalation | 1 | 2012 | 185 | 0.020 |
Why?
|
Tooth Fractures | 1 | 2011 | 27 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2716 | 0.020 |
Why?
|
Behavior, Addictive | 1 | 2016 | 429 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2023 | 2912 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2020 | 2163 | 0.020 |
Why?
|
Data Collection | 2 | 2011 | 3321 | 0.020 |
Why?
|
Marijuana Smoking | 1 | 2014 | 261 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2013 | 1765 | 0.020 |
Why?
|
Infant | 2 | 2023 | 36485 | 0.020 |
Why?
|
Parietal Lobe | 1 | 2015 | 861 | 0.020 |
Why?
|
Physicians | 1 | 2008 | 4593 | 0.020 |
Why?
|
Insurance, Dental | 1 | 2011 | 64 | 0.020 |
Why?
|
Criminal Psychology | 1 | 2009 | 15 | 0.020 |
Why?
|
Algorithms | 2 | 2022 | 14098 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2012 | 490 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 950 | 0.020 |
Why?
|
Bruxism | 1 | 2009 | 13 | 0.020 |
Why?
|
Association | 1 | 2009 | 53 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2013 | 497 | 0.020 |
Why?
|
Microglia | 1 | 2018 | 1370 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 1990 | 11513 | 0.020 |
Why?
|
Molecular Weight | 1 | 2011 | 2168 | 0.020 |
Why?
|
Faith Healing | 1 | 2009 | 26 | 0.020 |
Why?
|
Failed Back Surgery Syndrome | 1 | 2009 | 21 | 0.020 |
Why?
|
Nocturnal Myoclonus Syndrome | 1 | 2009 | 52 | 0.020 |
Why?
|
Health Care Costs | 1 | 2022 | 3239 | 0.020 |
Why?
|
Employment | 1 | 2015 | 1110 | 0.020 |
Why?
|
Species Specificity | 1 | 2013 | 2412 | 0.020 |
Why?
|
Medicine, Traditional | 1 | 2009 | 89 | 0.020 |
Why?
|
Sampling Studies | 1 | 2010 | 614 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 533 | 0.020 |
Why?
|
Social Environment | 1 | 2013 | 1012 | 0.020 |
Why?
|
Nonprescription Drugs | 1 | 2009 | 119 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8890 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9360 | 0.020 |
Why?
|
Coronary Thrombosis | 1 | 1990 | 440 | 0.020 |
Why?
|
Urinalysis | 1 | 2009 | 369 | 0.020 |
Why?
|
Lipids | 1 | 2018 | 3322 | 0.020 |
Why?
|
Neurotoxicity Syndromes | 1 | 2011 | 302 | 0.020 |
Why?
|
Abscess | 1 | 2011 | 606 | 0.020 |
Why?
|
Medication Errors | 1 | 2013 | 784 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 81659 | 0.020 |
Why?
|
Drug Utilization | 2 | 2003 | 1190 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2905 | 0.020 |
Why?
|
Receptor, Galanin, Type 2 | 1 | 2006 | 2 | 0.020 |
Why?
|
Pyridines | 1 | 2018 | 2890 | 0.020 |
Why?
|
Sick Role | 1 | 2007 | 229 | 0.020 |
Why?
|
Medically Underserved Area | 1 | 2009 | 268 | 0.020 |
Why?
|
Walking | 1 | 2013 | 1201 | 0.020 |
Why?
|
Serotonin | 1 | 2011 | 1045 | 0.020 |
Why?
|
Causality | 1 | 2012 | 1253 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8351 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2011 | 2677 | 0.020 |
Why?
|
Professional Role | 1 | 2009 | 315 | 0.020 |
Why?
|
Child | 2 | 2023 | 80771 | 0.020 |
Why?
|
Body Image | 1 | 2010 | 646 | 0.020 |
Why?
|
Health Services | 1 | 2010 | 755 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2783 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2018 | 3986 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6813 | 0.010 |
Why?
|
Endometriosis | 1 | 2012 | 873 | 0.010 |
Why?
|
Decision Making | 1 | 2017 | 3951 | 0.010 |
Why?
|
Physical Examination | 1 | 2009 | 1265 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2011 | 2131 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5363 | 0.010 |
Why?
|
Personality Assessment | 1 | 2005 | 646 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2013 | 18330 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2021 | 4629 | 0.010 |
Why?
|
Survivors | 1 | 2013 | 2381 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3928 | 0.010 |
Why?
|
Pyrimidines | 1 | 2015 | 3044 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2337 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26396 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2744 | 0.010 |
Why?
|
Sickness Impact Profile | 1 | 2003 | 299 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3370 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30238 | 0.010 |
Why?
|
Animals | 4 | 2018 | 168965 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6975 | 0.010 |
Why?
|
Electrocardiography | 1 | 2015 | 6409 | 0.010 |
Why?
|
Societies, Medical | 1 | 2014 | 3964 | 0.010 |
Why?
|
Heart Rate | 1 | 2012 | 4209 | 0.010 |
Why?
|
Spinal Cord | 1 | 2009 | 1811 | 0.010 |
Why?
|
Life Style | 1 | 2012 | 3931 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13085 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4881 | 0.010 |
Why?
|
Family Health | 1 | 2004 | 1254 | 0.010 |
Why?
|
Gene Frequency | 1 | 2006 | 3621 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9551 | 0.010 |
Why?
|
Neurons | 1 | 2018 | 9517 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1641 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4968 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4114 | 0.010 |
Why?
|
Length of Stay | 1 | 2010 | 6489 | 0.010 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2009 | 1897 | 0.010 |
Why?
|
Mice | 2 | 2013 | 81912 | 0.010 |
Why?
|
Hypertension | 1 | 2015 | 8615 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22361 | 0.010 |
Why?
|
Genetic Testing | 1 | 2006 | 3591 | 0.010 |
Why?
|
Genetic Variation | 1 | 2006 | 6611 | 0.010 |
Why?
|
Hospitalization | 1 | 2010 | 10815 | 0.010 |
Why?
|
Family | 1 | 2000 | 3210 | 0.000 |
Why?
|
Mutation | 1 | 2006 | 30211 | 0.000 |
Why?
|